Literature DB >> 4313728

Single-dose metyrapone test.

W Jubiz, A W Meikle, C D West, F H Tyler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4313728

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  8 in total

1.  Corticosteroid secretion: responses to alpha1-24 corticotropin, metyrapone and dexamethasone.

Authors:  T F Frawley
Journal:  Trans Am Clin Climatol Assoc       Date:  1972

2.  Case reports. Graves hyperthyroidism following myxedema in a patient with recurrent carcinoma of the colon.

Authors:  G A Levine; D E Williams; J M Hershman; G N Beall
Journal:  West J Med       Date:  1978-03

3.  Effect of the adrenocorticostatic agent, metopirone, on thermoregulatory heat production in the European hedgehog*.

Authors:  R Werner; W Wünnenberg
Journal:  Pflugers Arch       Date:  1980-05       Impact factor: 3.657

4.  Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.

Authors:  R J Santen; C W Bardin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

5.  Comparison of insulin hypoglycemia and short metyrapone tests in patients with pituitary disease.

Authors:  K Achenbach; W Oelkers
Journal:  Klin Wochenschr       Date:  1985-08-16

6.  Comparison of budesonide and beclomethasone dipropionate for treatment of asthma.

Authors:  C Springer; A Avital; C Maayan; A Rosler; S Godfrey
Journal:  Arch Dis Child       Date:  1987-08       Impact factor: 3.791

7.  An acute rise in serum phosphorus after single-dose oral metyrapone.

Authors:  S Akgun; N H Ertel; G Schneider
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 8.  Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis.

Authors:  Zuleyha Karaca; Ashley Grossman; Fahrettin Kelestimur
Journal:  Rev Endocr Metab Disord       Date:  2021-03-26       Impact factor: 6.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.